HALOZYME HALO -110-101 for Liver and Biliary Cancers - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if the two study drugs PEGPH20 and Atezolizumab given with the current standard of care medications Cisplatin and Gemcitabine are safe and to find out what dose will work in patients with liver or biliary cancers.
Liver and biliary cancers
Who Can Participate in the Study?
-Have previously untreated, locally advanced or metastatic ICC, ECC, and gallbladder adenocarcinoma
What is Involved?
you choose to join this study, you will:
-Be randomized (like drawing numbers out of a hat) to get either:
-- The combination of PEGPH20, cisplatin and gemcitabine
-- PEGPH20, atezolizumab, cisplatin and gemcitabine,
-- The standard of care for your cancer, which is cisplatin and gemcitabine
- Have tests, exams, and procedures that are part of your standard care and for study purposes.
-- Each clinic visit will last 4-5 hours